Total Payments
$3,014
2024 Payments
$304.35
Companies
7
Transactions
21
Medicare Patients
1,462
Medicare Billing
$102,228
Payment Breakdown by Category
Other$2,500 (82.9%)
Food & Beverage$474.76 (15.8%)
Travel$39.20 (1.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $2,500 | 1 | 82.9% |
| Food and Beverage | $474.76 | 19 | 15.8% |
| Travel and Lodging | $39.20 | 1 | 1.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Konica Minolta Healthcare Americas, Inc | $2,500 | 1 | $0 (2019) |
| ABBVIE INC. | $333.43 | 7 | $0 (2024) |
| Genentech USA, Inc. | $111.94 | 8 | $0 (2022) |
| Merck Sharp & Dohme Corporation | $26.12 | 2 | $0 (2018) |
| Oxford Immunotec USA Inc | $15.44 | 1 | $0 (2018) |
| GlaxoSmithKline, LLC. | $14.49 | 1 | $0 (2019) |
| Indivior Inc. | $12.54 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $304.35 | 5 | ABBVIE INC. ($304.35) |
| 2023 | $29.08 | 2 | ABBVIE INC. ($29.08) |
| 2022 | $12.68 | 1 | Genentech USA, Inc. ($12.68) |
| 2021 | $45.00 | 3 | Genentech USA, Inc. ($45.00) |
| 2020 | $40.76 | 3 | Genentech USA, Inc. ($40.76) |
| 2019 | $2,528 | 3 | Konica Minolta Healthcare Americas, Inc ($2,500) |
| 2018 | $41.56 | 3 | Merck Sharp & Dohme Corporation ($26.12) |
| 2017 | $12.54 | 1 | Indivior Inc. ($12.54) |
All Payment Transactions
21 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/01/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $63.29 | General |
| Category: FACIAL AESTHETICS | ||||||
| 11/01/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $54.26 | General |
| Category: FACIAL AESTHETICS | ||||||
| 11/01/2024 | ABBVIE INC. | BOTOX (Biological) | Travel and Lodging | In-kind items and services | $39.20 | General |
| Category: FACIAL AESTHETICS | ||||||
| 11/01/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $22.61 | General |
| Category: FACIAL AESTHETICS | ||||||
| 10/15/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $124.99 | General |
| 03/28/2023 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $16.38 | General |
| 03/17/2023 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $12.70 | General |
| 01/19/2022 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $12.68 | General |
| Category: Virology & Specialty Care | ||||||
| 10/18/2021 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Virology & Specialty Care | ||||||
| 02/09/2021 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Virology & Specialty Care | ||||||
| 01/12/2021 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Virology & Specialty Care | ||||||
| 12/02/2020 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $12.26 | General |
| Category: Virology & Specialty Care | ||||||
| 11/05/2020 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $13.50 | General |
| Category: Virology & Specialty Care | ||||||
| 01/20/2020 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Virology & Specialty Care | ||||||
| 12/03/2019 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $13.50 | General |
| Category: Virology & Specialty Care | ||||||
| 07/17/2019 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), BEXSERO, BOOSTRIX | Food and Beverage | In-kind items and services | $14.49 | General |
| Category: VACCINES | ||||||
| 04/18/2019 | Konica Minolta Healthcare Americas, Inc | — | Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | Cash or cash equivalent | $2,500.00 | General |
| 09/27/2018 | Oxford Immunotec USA Inc | TSPOT TB TEST (Device) | Food and Beverage | In-kind items and services | $15.44 | General |
| Category: Diagnostic Test | ||||||
| 05/10/2018 | Merck Sharp & Dohme Corporation | SIVEXTRO (Drug) | Food and Beverage | In-kind items and services | $12.08 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 04/24/2018 | Merck Sharp & Dohme Corporation | SIVEXTRO (Drug) | Food and Beverage | In-kind items and services | $14.04 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 10/11/2017 | Indivior Inc. | SUBOXONE SUBLINGUAL FILM (Drug) | Food and Beverage | Cash or cash equivalent | $12.54 | General |
| Category: OUD | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 305 | 350 | $48,744 | $19,427 |
| 2022 | 13 | 477 | 546 | $65,771 | $39,062 |
| 2021 | 7 | 249 | 261 | $18,067 | $13,094 |
| 2020 | 9 | 431 | 445 | $47,855 | $30,645 |
Total Patients
1,462
Total Services
1,602
Medicare Billing
$102,228
Procedure Codes
39
All Medicare Procedures & Services
39 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 55 | 67 | $12,931 | $6,061 | 46.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 59 | 68 | $11,220 | $4,369 | 38.9% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2023 | 52 | 62 | $5,580 | $2,514 | 45.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 20 | 20 | $6,520 | $2,351 | 36.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 36 | 36 | $8,532 | $2,251 | 26.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 24 | 24 | $840.00 | $815.28 | 97.1% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2023 | 22 | 22 | $506.00 | $481.80 | 95.2% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 14 | 28 | $1,428 | $454.16 | 31.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 11 | 11 | $935.00 | $102.88 | 11.0% |
| 81003 | Automated urinalysis test | Office | 2023 | 12 | 12 | $252.00 | $26.40 | 10.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 106 | 128 | $16,334 | $10,795 | 66.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 50 | 63 | $10,416 | $6,982 | 67.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 51 | 51 | $9,707 | $5,080 | 52.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 31 | 31 | $8,608 | $4,571 | 53.1% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2022 | 90 | 94 | $8,460 | $3,825 | 45.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 11 | 11 | $3,113 | $2,625 | 84.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 13 | 13 | $2,640 | $2,546 | 96.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 30 | 30 | $1,050 | $1,011 | 96.3% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2022 | 28 | 56 | $2,856 | $908.32 | 31.8% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2022 | 24 | 24 | $960.00 | $506.16 | 52.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 11 | 11 | $935.00 | $128.53 | 13.7% |
| 81003 | Automated urinalysis test | Office | 2022 | 21 | 23 | $483.00 | $50.87 | 10.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 11 | 11 | $209.00 | $32.43 | 15.5% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 67 | 67 | $6,467 | $4,372 | 67.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 15 | 24 | $3,457 | $2,690 | 77.8% |
About William Gluckman, DO, MBA
William Gluckman, DO, MBA is a Emergency Medicine healthcare provider based in Morris Plains, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/31/2006. The National Provider Identifier (NPI) number assigned to this provider is 1336225424.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, William Gluckman, DO, MBA has received a total of $3,014 in payments from pharmaceutical and medical device companies, with $304.35 received in 2024. These payments were reported across 21 transactions from 7 companies. The most common payment nature is "Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program" ($2,500).
As a Medicare-enrolled provider, Gluckman has provided services to 1,462 Medicare beneficiaries, totaling 1,602 services with total Medicare billing of $102,228. Data is available for 4 years (2020–2023), covering 39 distinct procedure/service records.
Ad
Practice Information
- Specialty Emergency Medicine
- Location Morris Plains, NJ
- Active Since 10/31/2006
- Last Updated 09/20/2008
- Taxonomy Code 207P00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1336225424
Products in Payments
- BOTOX (Biological) $179.36
- Xofluza (Drug) $111.94
- SIVEXTRO (Drug) $26.12
- TSPOT TB TEST (Device) $15.44
- SHINGRIX (Biological) $14.49
- SUBOXONE SUBLINGUAL FILM (Drug) $12.54
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.